Cells4Health

Cells4Health was a Dutch biotechnology company that specialized in the development and administration of autologous stem cell therapies. The company utilized stem cells derived from a patient's own bone marrow to treat various chronic and degenerative conditions, including diabetes, heart disease, and neurological disorders. Cells4Health operated primarily as a provider of experimental treatments, often attracting international patients seeking alternatives to conventional medicine. The company's approach involved isolating mononuclear cells from bone marrow aspirate and re-injecting them into the patient to stimulate tissue repair. However, the company faced significant regulatory challenges and was eventually forced to cease its operations in the Netherlands. These challenges stemmed from concerns raised by health authorities regarding treatment safety, lack of standardized clinical trials, and unproven efficacy.